The First and Longest ECCT User for Lung Cancer Surpasses 12 Years, Following the Advice of the First Doctor to Accept ECCT
Diagnosed with advanced-stage lung cancer in 2011, Mr. Abdulmalik faced grim odds—most patients in his condition survive less than five years. When conventional options offered little hope, his doctor, the first to accept ECCT, suggested he try the new therapy. Mr. Abdulmalik agreed, becoming the first person to use ECCT for lung cancer.
Within a month, his coughing blood subsided, and CT scans showed the tumor had shrunk by half. Over the following years, his condition steadily improved—breathing became normal, and by the third year, only scar tissue remained where the tumor once was.
Now, more than ten years later, Mr. Abdulmalik remains strong, active, and cancer-free—living proof of how determination and innovation can defy even the deadliest odds.